Understanding how changes in cell communication affect type 1 diabetes
Implications of Changes in Islet Exosomal Cargo in Type 1 Diabetes
This study is looking at tiny particles called exosomes that come from insulin-producing cells in the pancreas to see how they change in type 1 diabetes and if they can help protect these cells from damage, focusing on a special protein that might help them survive better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10908578 on NIH RePORTER |
What this research studies
This research investigates the role of extracellular vesicles, specifically exosomes released by beta cells, in the communication between cells in the pancreas. It aims to understand how these exosomes change in type 1 diabetes and how they may help protect beta cells from autoimmune destruction. The study will explore the mechanisms behind the presence of a protein called PD-L1 on these exosomes, which may play a crucial role in beta cell survival. By using various chemical and genetic techniques, the researchers will assess how inflammation affects the content of these exosomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 1 diabetes who may benefit from advancements in treatment aimed at preserving beta cell function.
Not a fit: Patients with type 2 diabetes or other forms of diabetes unrelated to autoimmune processes may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for protecting beta cells in patients with type 1 diabetes.
How similar studies have performed: Other research has shown promising results in understanding the role of exosomes in cell communication and autoimmune diseases, suggesting potential for success in this area.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Sims, Emily K — Indiana University Indianapolis
- Study coordinator: Sims, Emily K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.